# Confo Therapeutics

> GPCR stabilization for drug discovery

Business model and tags: Pharma & life sciences, Has in-house R&D

## About Confo Therapeutics

Innovative technology stabilizes GPCRs for drug target discovery, leading to a potential pipeline of transformative therapies for severe diseases

## Key facts

- **Industry**: Biotechnology
- **Company size**: 51–250 employees
- **Headquarters**: Zwijnaarde, Flanders, Belgium
- **Founded**: 2015
- **Revenue**: €12M – €95.1M (Tamtam estimate)
- **Website**: [confotherapeutics.com](https://www.confotherapeutics.com/)
- **LinkedIn**: [linkedin.com/company/confo-therapeutics](https://www.linkedin.com/company/confo-therapeutics)

## Confo Therapeutics at a glance

Confo Therapeutics is a company in the Biotechnology industry, headquartered in Zwijnaarde, Flanders, Belgium.

Confo Therapeutics was founded in 2015.

Confo Therapeutics has 51–250 employees.

Confo Therapeutics's revenue is €12M – €95.1M (Tamtam estimate).

## Frequently asked questions about Confo Therapeutics

### What is Confo Therapeutics's revenue?

Tamtam estimates Confo Therapeutics's annual revenue at €12M – €95.1M.

### How many employees does Confo Therapeutics have?

Confo Therapeutics has 51–250 employees.

### Where is Confo Therapeutics headquartered?

Confo Therapeutics is headquartered in Zwijnaarde, Flanders, Belgium.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/confo-therapeutics